Shares in AIM- listed biomedical firm Netscientific PLC (LON:NSCI) ticked higher as it hailed the appointment of a renowned cardiologist as medical director at its California- based portfolio firm Wanda.
She is Dr Suzanne Steinbaum, a board-certified cardiologist and well-known national advocate for women's heart health, the group said.
Wanda is a digital analytics software group, whose aim is to reduce US hospital admissions.
It has developed a way to digitally monitor people with congestive heart failure and other chronic conditions, so that specialists can monitor risk and lower readmissions.
Dr Steinbaum said: "Wanda is at the forefront of a critical turning point in healthcare, in which patient engagement is essential to successful outcomes.
"I have devoted my entire career to the treatment of heart disease through early detection, education, and prevention."
She added :"While heart disease is 80 to 90% preventable, lifestyle changes are critical, and this is where Wanda comes in."
François R. Martelet, chief executive at NetScientific said: "Dr Steinbaum's extensive clinical experience and background in cardiology will make her a valuable addition to Wanda's already distinguished team."
Shares in NetScientific added 0.67% to stand at 75.5p a pop.